Unicycive Therapeutics, Inc. (UNCY)
NASDAQ · Manufacturing · Pharmaceutical preparations
$4.75−$0.0600 (−1.25%) on the dayAs of the close; data may be delayed.
UNCY price, last 12 months
Key stats
- Previous close
- $4.81
- Open
- $4.89
- Day range
- $4.66 – $4.89
- 52-week range
- $3.71 – $8.74
- Volume
- 466.6K
- Avg volume (20 days)
- 799.7K
- Market cap
- $130.8M
Performance
1W−1.0%
1M−12.5%
3M−33.4%
6M−28.4%
YTD−17.7%
1Y+23.4%
vs S&P 500, 1Y+6.6 pts
Technicals and fundamentals
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $130.8M